Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Investigation of the Performance of the Medical Device Dermalyser in Determining Melanoma Thickness Based on Dermoscopy Images
This clinical trial aims to evaluate the performance of the Dermalyser device in determining melanoma thickness from dermoscopy images; the …
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: T-cell Therapy with CRISPR PD1-edited Tumor Infiltrating Lymphocytes for Patients with Metastatic Melanoma [Phase 1]
A Phase 1 clinical trial evaluating CRISPR PD-1-edited tumor-infiltrating lymphocytes for metastatic melanoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Clinical and Ultrasound Incidence of Rheumatologic Immune Related Adverse Events in Stage IIB-IV Melanoma Patients
A clinical trial update assessing the clinical and ultrasound incidence of rheumatologic immune-related adverse events in melanoma patients …
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial [NA]
A clinical trial from Leiden University Medical Center is evaluating EMDR therapy as a waiting-list controlled intervention to reduce fear o…
-
CLINICAL_TRIALS research · 2024-12-19Clinical Trial Update: A Study of IBI363 in Subjects with Advanced Solid Malignancies [Phase 2]
Phase 2 study of IBI363 in advanced solid malignancies is currently recruiting, with indications including melanoma, non-small cell lung can…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: Rural Adult and Youth Sun Protection Study [NA]
A clinical trial update for the Rural Adult and Youth Sun Protection Study, sponsored by the University of Utah, currently recruiting for me…
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: A Phase Ib Study of PRJ1-3024 for Treatment of Advanced or Metastatic Melanoma [Phase 1, Phase 2]
Zhuhai Yufan Biotechnologies Co., Ltd. is conducting a Phase Ib/Phase II trial of PRJ1-3024 for advanced or metastatic melanoma. The study i…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Family History App in Personalized Medicine [NA]
An update on a university-sponsored clinical trial evaluating a family history app for personalized medicine; the study is currently active …
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Cognitive Function in Melanoma Patients Treated With Adjuvant Immune Checkpoint Inhibitors
An update on an ongoing trial at Aarhus University Hospital evaluating cognitive function in melanoma patients treated with adjuvant immune …
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating IOV-4001 for unresectable or metastatic melanoma and stage III/IV non-small cell lung cancer is currently recruit…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9
A clinical trial is evaluating the PET imaging tracer 68Ga-DOTA-Siglec-9 in cancer patients. The study is currently enrolling by invitation …
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Ontario-wide Cancer TArgeted Nucleic Acid Evaluation
An Ontario-wide clinical trial evaluating targeted nucleic acid analysis for cancer is currently recruiting across multiple cancer types, pe…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Power of Liquid Biopsy Tracking in Immunotherapy Treated Stage IV Melanoma
Clinical trial update describing a study using liquid biopsy tracking in immunotherapy-treated stage IV melanoma; the trial is not yet recru…
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: Examining the Risk of Skin Cancer in Multiple Sclerosis Patients Using Fingolimod: a Population-Based Study
This completed population-based study investigates whether fingolimod use in people with multiple sclerosis is associated with skin cancer r…
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067 [Phase 1, Phase 2]
Phase 1a/Phase 2 study evaluating safety, preliminary efficacy, PK and PD of ST-067 in various cancers; currently recruiting.
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: Impact of Physical Activity on Immunotherapy-induced Toxicities in Melanoma Management
A clinical trial investigates whether physical activity influences immunotherapy-related toxicities in melanoma patients. The study is curre…
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma [Phase 1, Phase 2]
The document reports ongoing recruitment for a phase 1/phase 2 trial evaluating intradermal ipilimumab plus nivolumab in high-risk stage II …
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY) [Phase 1, Phase 2]
Phase I/IIa dose-finding study evaluating a triplet regimen of relatlimab, ipilimumab, and nivolumab as first-line therapy for metastatic me…
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: The 4D PICTURE Project: Evaluating Metro Mapping As a Method to Support Shared Decision Making in Oncology
This clinical trial update describes the 4D PICTURE Project evaluating Metro Mapping to support shared decision making in oncology, sponsore…
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young Adults
A recruiting clinical study from University Hospital Tuebingen investigating risk factors, exposomics, and genetic susceptibility for melano…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal Cancer [Phase 2]
A Phase 2 clinical trial update on Cardonilmab for second-line or higher advanced melanoma and advanced renal cancer, focusing on safety and…
-
CLINICAL_TRIALS research · 2024-10-31Clinical Trial Update: DermaSensor Postmarket Surveillance Study [NA]
DermaSensor, Inc. is conducting a postmarket surveillance clinical trial to monitor device performance in melanoma/skin conditions; the stud…
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Validation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node Biopsy [NA]
The Netherlands Cancer Institute reports ongoing recruitment for a trial validating ICG-99mTc-nanoscan as a hybrid tracer for sentinel lymph…
-
CLINICAL_TRIALS research · 2024-10-26Clinical Trial Update: NeoLIPA: Neoadjuvant LTX-315 in Combination with Pembrolizumab in Resectable Stage III/IV Melanoma [Phase 2]
A Phase 2 trial, NeoLIPA, is evaluating neoadjuvant LTX-315 in combination with pembrolizumab for resectable stage III/IV melanoma and is cu…
-
CLINICAL_TRIALS research · 2024-10-26Clinical Trial Update: Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma Patients [Phase 2]
Phase 2 clinical trial evaluating intratumoral L19IL2 or L19TNF or L19IL2/L19TNF in combination with pembrolizumab for unresectable melanoma…